📖 Your Q2 Earnings Guide: Discover the Stocks ProPicks AI Highlights to Jump Post-EarningsRead more

Usana Health Sciences insider sells $179,857 in company stock

Published 06/11/2024, 09:59 PM
USNA
-

An insider of USANA Health (NYSE:USNA) Sciences Inc. (NYSE:USNA), a global nutritional company, has sold shares in the company, according to a recent SEC filing. The transaction involved the sale of 3,700 shares at a price of $48.61 each, totaling $179,857.

The shares were sold on June 7, 2024, by Gull Global Ltd, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Post-transaction, the shares owned by Gull Global Ltd amount to 7,880,043. It's important to note that Gull Global Ltd is directly owned 50% by Viron Company Limited and 50% by Myogen Limited, both of which are companies formed under the Commonwealth of the Bahamas and are wholly indirectly owned and controlled by Dr. Wentz.

The transaction was signed off by Valarie A. Hing, Attorney-in-Fact, on June 11, 2024. This sale reflects a single-day transaction, and the stated price provides a snapshot of the stock's value at the time of the sale.

Investors and market watchers often monitor insider transactions as they can provide insights into how executives and significant shareholders view the stock's value and future performance. However, it's also common for insiders to sell stock for personal financial management reasons that may not necessarily reflect their outlook on the company's future prospects.

USANA Health Sciences Inc . specializes in the production and distribution of nutritional supplements and skincare products. The company is headquartered in Salt Lake City, Utah, and operates in various international markets, providing products that are used by customers worldwide.

In other recent news, USANA Health Sciences Inc. experienced a blend of triumphs and challenges in the first quarter of 2024. The company's earnings report revealed a 5% year-over-year decrease in consolidated net sales, totaling $228 million in constant currency terms, and a diluted earnings per share (EPS) of $0.86. Despite this, a successful sales promotion in Mainland China led to a 10% growth in local currency net sales and a 15% increase in active customers.

DA Davidson revised its outlook on USANA, reducing the price target to $46 from the previous $48, following mixed performance across the company's market segments. The firm also revised its second-quarter 2024 EPS estimate for USANA to $0.68, down from $0.75, in response to anticipated challenges in key markets and consumer price sensitivity.

These are recent developments for USANA, which also highlighted its financial health by reporting a net cash position of approximately $17 per share. The company plans to introduce market-specific incentives and a robust product strategy to stimulate growth and navigate the shifting market conditions.

InvestingPro Insights

Amid the news of insider transactions at USANA Health Sciences Inc. (NYSE:USNA), investors might find it valuable to consider some key financial metrics and insights from InvestingPro. With a market capitalization of $898.42 million and a Price/Earnings (P/E) ratio standing at 14.41, USANA appears to be trading at a low earnings multiple, which might attract value investors looking for potentially undervalued stocks. The company's gross profit margins are notably high at nearly 81% for the last twelve months as of Q1 2024, indicating strong operational efficiency in generating profits from its sales.

One of the standout InvestingPro Tips highlights that USANA holds more cash than debt on its balance sheet, suggesting a solid financial position that could provide resilience in uncertain economic times. Additionally, the company's liquid assets exceed its short-term obligations, which bolsters the company's short-term financial stability. It is also worth noting that analysts predict the company will be profitable this year, a sentiment that could reassure investors of the company's ongoing ability to generate positive earnings.

While insider sales can signal various things, understanding the broader financial context can help investors make more informed decisions. For those interested in a deeper dive into USANA's financial health and future prospects, there are additional InvestingPro Tips available. With a wealth of financial analysis at their fingertips, readers can use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, providing access to an expanded array of insights and metrics for USANA. Currently, there are 9 additional InvestingPro Tips listed for USANA, which can be found at https://www.investing.com/pro/USNA.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.